CREB1 and Parkinson disease: The purpose of this study is to determine the impact of designed bioactive LNPs and lipid-peptide nanoassemblies, with different liquid crystalline structural organizations, on the kinetics of CREB activation and neuronal cell recovery from oxidative stress in a PD model in vitro.